98 related articles for article (PubMed ID: 10442373)
21. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Hoff PM; Pazdur R; Benner SE; Canetta R
Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
[TBL] [Abstract][Full Text] [Related]
22. Preoperative UFT and calcium folinate and radiotherapy in rectal cancer.
Hoff PM; Lassere Y; Pazdur R; Janjan N; Crane C; Skibber J
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):129-31. PubMed ID: 10442382
[TBL] [Abstract][Full Text] [Related]
23. UFT plus calcium folinate plus radiotherapy for recurrent rectal cancer.
Hoffmann W; Schiebe M; Dethling J; Martin C
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):125-6. PubMed ID: 10442380
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL
J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535
[TBL] [Abstract][Full Text] [Related]
25. Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer.
Meropol NJ; Sonnichsen DS; Birkhofer MJ; Ferreira I; Noel D
Cancer Chemother Pharmacol; 1999; 43(3):221-6. PubMed ID: 9923552
[TBL] [Abstract][Full Text] [Related]
26. A phase 2 study of a fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in a 3-times-daily regimen to treat patients with recurrent metastatic breast cancer.
Hortobagyi GN; Heim W; Hutchins L; Rivera E; Mason B; Booser DJ; Kirshner J
Cancer; 2010 Mar; 116(6):1440-5. PubMed ID: 20091835
[TBL] [Abstract][Full Text] [Related]
27. Phase I study of paclitaxel and uracil plus tegafur combination in patients with pretreated metastatic breast cancer: drug sequencing based on preclinical modelling studies.
Passardi A; Maltoni R; Milandri C; Cecconetto L; Massa I; Zoli W; Tesei A; Fabbri F; Nanni O; Amadori D
Oncology; 2007; 72(1-2):118-24. PubMed ID: 18004083
[TBL] [Abstract][Full Text] [Related]
28. Phase I - II study of oral idarubicin, tegafur and levo-folinate in patients with pretreated advanced breast cancer.
Cilenti G; Tozzi L; Suriano A; Tartarone A; Lelli G
J Chemother; 1999 Oct; 11(5):402-6. PubMed ID: 10632388
[TBL] [Abstract][Full Text] [Related]
29. Preoperative combined oral UFT plus leucovorin and radiation therapy for rectal cancer.
Diaz-Canton E; Pazdur R
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):58-60. PubMed ID: 9348571
[TBL] [Abstract][Full Text] [Related]
30. A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancer.
Hortobagyi GN; Young RR; Karwal M; Ibrahim NK; Hermann R; Murray JL; Watkins SP; Gore I
Cancer; 2010 May; 116(10):2301-6. PubMed ID: 20225231
[TBL] [Abstract][Full Text] [Related]
31. Phase I trial of uracil-ftorafur, leucovorin, and etoposide: an active all-oral regimen for metastatic breast cancer.
Hartman AR; Grekowicz A; Lum BL; Carlson RW; Schurman C; Sikic BI; Shapiro R; Stockdale FE
Breast Cancer Res Treat; 2003 Nov; 82(1):61-9. PubMed ID: 14672404
[TBL] [Abstract][Full Text] [Related]
32. A phase II trial. Oral UFT and leucovorin in patients with advanced gastric carcinoma.
Kim YH; Shin SW; Kim BS; Park YT; Kim JG; Kim JS
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):119-23. PubMed ID: 9348583
[TBL] [Abstract][Full Text] [Related]
33. UFT/leucovorin plus vinorelbine combination for advanced breast cancer.
Fumoleau P; Déporte R; Kerbrat P; Bonneterre J; Fargeot P
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):50-5. PubMed ID: 11098494
[TBL] [Abstract][Full Text] [Related]
34. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
[TBL] [Abstract][Full Text] [Related]
35. Impact of uracil/tegafur plus oral calcium folinate on resource utilization.
Ollendorf D
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):42-3. PubMed ID: 10442359
[TBL] [Abstract][Full Text] [Related]
36. A phase I study. Preoperative UFT/leucovorin and radiation therapy in rectal cancer.
Hoff PM; Saad ED; Janjan N; Skibber J; Pazdur R
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):56-8. PubMed ID: 11098495
[TBL] [Abstract][Full Text] [Related]
37. UFT plus oral folinic acid with alternating oral and intravenous vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.
Coşkun U; Kaya AO; Alkis N; Buyukberber S; Alici S; Celenkoglu G; Uncu D; Ozkan M; Sevinc A; Benekli M
Onkologie; 2009 Oct; 32(10):562-6. PubMed ID: 19816072
[TBL] [Abstract][Full Text] [Related]
38. UFT/leucovorin vs 5-FU/leucovorin in colon cancer.
Smith RE; Lembersky BC; Wieand HS; Colangelo L; Mamounas EP
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):24-7. PubMed ID: 11098486
[TBL] [Abstract][Full Text] [Related]
39. Retrospective study of S-1 versus tegafur/uracil and oral leucovorin in patients with metastatic colorectal cancer.
Shibahara K; Yamamoto M; Kakeji Y; Sakata H; Maehara Y
Anticancer Res; 2008; 28(3B):1779-83. PubMed ID: 18630459
[TBL] [Abstract][Full Text] [Related]
40. Modelling of ftorafur and 5-fluorouracil pharmacokinetics following oral UFT administration. A population study in 30 patients with advanced breast cancer.
Urien S; Fumoleau P; Campone M; Kerbrat P; Bonneterre J; Fargeot P; Deporte-Fety R
Cancer Chemother Pharmacol; 2003 Aug; 52(2):99-107. PubMed ID: 12768319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
